Earnings call transcript: Curtiss-Wright Q1 2026 beats expectations, stock dips

Curtiss-Wright delivered a strong Q1 2026 beat, with EPS of $3.48 versus $3.28 expected and revenue of $914 million versus $864.31 million, while operating margin expanded 100 bps to 17.6%. Management raised full-year 2026 guidance, now targeting EPS of $14.90-$15.30, sales growth of 7%-8%, and operating margin of 19.0%-19.2%, supported by a 1.3x book-to-bill and record $4.3 billion backlog. Despite the positive results, the stock fell 0.62% in after-hours trading.

Analysis

CW’s print is more important as a read-through on defense and nuclear capex than as a one-quarter beat. The key second-order signal is that management is now effectively converting backlog into margin faster than revenue, which usually happens late in an upcycle when supply-chain bottlenecks ease and pricing discipline holds. That matters for peers with less backlog quality or lower mix leverage: CW is pulling away from mid-cap defense suppliers that still need a clean budget environment to reaccelerate.

The market is likely underappreciating how much of the upside is coming from program timing normalization rather than one-off demand. Once delayed defense orders convert, the comp becomes self-reinforcing for several quarters, but the bigger takeaway is that CW is using those flows to fund R&D and capacity without sacrificing returns. That creates a moat expansion dynamic: the company can bid more aggressively on second-source opportunities while competitors with tighter balance sheets may be forced to choose between growth and margin.

The contrarian risk is that consensus may be over-discounting the durability of the nuclear and defense ramps. The company’s guidance embeds a lot of execution, and the biggest failure mode is not demand, but slippage in conversion on semis, rare earths, or large program timing. If those frictions reappear, the stock’s premium multiple becomes vulnerable because the market is already paying for a multi-year growth story, not just a clean quarter.

Key Decisions for Investors

• Stay long CW on any 2-3% pullback over the next 1-2 weeks; use the tape weakness as a buyable consolidation with a 3-6 month target tied to guide-up revisions and backlog visibility.
• Pair trade: long CW / short HON for the next 1-2 quarters. CW has more direct upside to defense and nuclear budget acceleration, while HON has less operating leverage to the same mix tailwinds.
• Initiate a small long in BA vs. short-term hedge through CW only if you want aerospace beta with higher specificity. CW is better positioned to monetize military aviation modernization than platform-exposed OEMs over the next 6-12 months.
• Buy CW Jan 2027 calls or call spreads if available. The setup is less about near-term EPS surprise and more about multiple expansion from sustained margin expansion and M&A optionality over 9-18 months.
• Avoid shorting CW despite the premium valuation; instead, hedge any defense exposure with a short basket of lower-quality suppliers most exposed to budget timing and input inflation.